about
Enzyme-linked immunospot and tuberculin skin testing to detect latent tuberculosis infection.Clinical outcomes among persons with pulmonary tuberculosis caused by Mycobacterium tuberculosis isolates with phenotypic heterogeneity in results of drug-susceptibility testsDoes directly observed therapy (DOT) reduce drug resistant tuberculosis?Unusual interferon gamma measurements with QuantiFERON-TB Gold and QuantiFERON-TB Gold In-Tube tests.Estimating the burden of tuberculosis among foreign-born persons acquired prior to entering the U.S., 2005-2009.Mycobacterium tuberculosis cluster with developing drug resistance, New York, New York, USA, 2003-2009.Using genotyping and geospatial scanning to estimate recent mycobacterium tuberculosis transmission, United States.Isoniazid preventive treatment in children in two districts of South India: does practice follow policy?Composite indicator: new tool for monitoring RNTCP performance in India.Use of tuberculosis genotyping for postoutbreak monitoring.Foreign-Born Status and Geographic Patterns of Tuberculosis Genotypes in Tarrant County, Texas.Does Alcohol consumption during multidrug-resistant tuberculosis treatment affect outcome?. A population-based study in Kerala, IndiaCharacterizing tuberculosis genotype clusters along the United States-Mexico border.Decline in tuberculosis among Mexico-born persons in the United States, 2000-2010.Acquired resistance to second-line drugs among persons with tuberculosis in the United States.Mortality among tuberculosis patients with acquired resistance to second-line antituberculosis drugs--United States, 1993-2008.Tuberculosis and excess alcohol use in the United States, 1997-2012.Airborne infection control in India: Baseline assessment of health facilities.Excess Alcohol Use and Death among Tuberculosis Patients in the United States, 1997-2012Can Intensified Tuberculosis Case Finding Efforts at Nutrition Rehabilitation Centers Lead to Pediatric Case Detection in Bihar, India?The value of effective public tuberculosis treatment: an analysis of opportunity costs associated with multidrug resistant tuberculosis in Latvia.Impact of awareness drives and community-based active tuberculosis case finding in Odisha, India.Molecular, Spatial, and Field Epidemiology Suggesting TB Transmission in Community, Not Hospital, Gaborone, Botswana.Integration and decentralisation of TB-HIV services increases HIV testing of TB cases in Rajasthan, India.Clinical and bacteriological characteristics associated with clustering of multidrug-resistant tuberculosis.Association between Mycobacterium tuberculosis lineage and time to sputum culture conversion.Tuberculosis genotyping information management system: enhancing tuberculosis surveillance in the United States.Relationship between Mycobacterium tuberculosis phylogenetic lineage and clinical site of tuberculosis.Tuberculosis and substance abuse in the United States, 1997-2006.Use of Verbal Autopsy to Determine Underlying Cause of Death during Treatment of Multidrug-Resistant Tuberculosis, India.Diagnostic pathways and direct medical costs incurred by new adult pulmonary tuberculosis patients prior to anti-tuberculosis treatment - Tamil Nadu, India.Operational research within a Global Fund supported tuberculosis project in India: why, how and its contribution towards change in policy and practice.The molecular epidemiology of human and zoonotic Mycobacterium bovis: the intersection between veterinary medicine and public healthTowards national systems for continuous surveillance of antimicrobial resistance: Lessons from tuberculosisMolecular epidemiology of Mycobacterium tuberculosis in the United States-Affiliated Pacific IslandsAssessing the impact of targeted tuberculosis interventionsUsing cost and health impacts to prioritize the targeted testing of tuberculosis in the United StatesWhat is the outcome of targeted tuberculosis screening based on universal genotyping and location?
P50
Q30489177-2D9FDA5B-E9AB-4E51-B869-0C20EBFF1A41Q33596103-1E635C8E-681C-4A60-8523-DC052F7B202AQ33788435-987A3071-B62A-4435-862D-610352A378A3Q33936808-84391B96-8D04-45F7-80C5-4F787937622CQ34090979-C7AC1701-CADC-49AE-9A54-A43F01091024Q35193485-A1989720-1A27-43FF-9265-BC907D69B173Q35844412-5FF995FA-20CC-4D8C-B48F-8787217EE11FQ36108326-ECFE9C4E-1EE1-40F0-9858-7AA4DE7B376BQ36126024-2D0C8207-7F80-4944-9CF3-E490F76EA630Q36182028-7B10EE2C-3CF9-4006-A3B3-BD807E917E46Q36200605-65B3847F-D24C-4940-9348-91E217579FEFQ36244615-FA23BDE0-B29C-4039-9725-0379BEDBDF00Q36479010-7B804781-1C50-4812-81A9-7581F9FD6305Q36562401-F691123C-40CC-40FB-8947-98DB7429BCAEQ36593003-9B4D420D-E35A-425E-A8A1-658671334E93Q36667717-3F27AD11-7874-4487-BCD9-A309C463DCF6Q36702589-89189F78-6DFA-48C6-BBC9-A4D35B5B4877Q36744993-7628DA4A-2BFD-46A7-8A44-0FC695B06992Q36763068-941F1CDB-0B4A-45B5-A3D6-C7D9315509A2Q36782011-E7EBCC82-6B21-4C88-8DD3-669911A05656Q36797843-AD266557-CB0B-4A87-A3DD-98D078E78CA7Q36899830-7FCC376D-CCA9-4002-B8F6-C607DECE0E32Q37739614-E967ECEA-38DD-41AC-8FF8-ECCD41AF4B2CQ40095170-D0E7D75F-207E-4E85-AFBA-45AAFE48FFE8Q40198502-D62B681B-AA09-4E8F-AA1E-C39B25B96B72Q42259912-8A63783B-E25B-4F4B-8E0D-737355973FAFQ44919403-2FBA688A-BF39-4C3C-98B4-E1CA10AA34EEQ45048517-0890582A-8BF7-426A-9CAC-542029803C66Q45931262-114FBE15-55F8-4CEC-898E-17DED89FA05FQ49820163-1D7C43CB-C39A-4A5C-8EE0-E7A9E4B4759BQ50055435-472EB216-C3A6-40A7-93FE-5A22E5B36AEBQ52649135-5249DB9E-2143-4FB9-946D-5EB9B6F066B7Q56772536-8CFD3FC6-0D7D-48D3-9DE8-EF7565EDD1B4Q58741327-0C4C3BCA-D8C0-4E79-A580-F3B9D962139DQ64127974-DE22077B-F208-4315-8F9B-8144E36AC53BQ80763008-5E024D1D-4C54-49DF-A7C5-6CEA48B0CFA8Q81389328-F51C30E4-4F6D-44E3-AA11-51D990961750Q83854592-CE8E6AF9-3F4F-4365-8FEA-E25F8B610F84
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Patrick K Moonan
@ast
Patrick K Moonan
@en
Patrick K Moonan
@es
Patrick K Moonan
@nl
type
label
Patrick K Moonan
@ast
Patrick K Moonan
@en
Patrick K Moonan
@es
Patrick K Moonan
@nl
prefLabel
Patrick K Moonan
@ast
Patrick K Moonan
@en
Patrick K Moonan
@es
Patrick K Moonan
@nl
P106
P1153
7801593497
P31
P496
0000-0002-3550-2065